ABRT — Albert Labs International Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Albert Labs International, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.28 | -0.135 | -0.284 | -0.282 | -7.06 |
Depreciation | |||||
Non-Cash Items | 0.285 | 0.08 | 0.24 | 0.24 | 6.17 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.058 | 0.036 | 0.026 | 0.099 | -0.544 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.053 | -0.019 | -0.018 | 0.057 | -1.43 |
Capital Expenditures | — | — | — | — | -0.064 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | — | -0.012 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | — | — | -0.076 |
Financing Cash Flow Items | 0.052 | -0.014 | 0 | — | 0.088 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.052 | 0.019 | 0.018 | -0.057 | 1.51 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0 | 0 | 0 | 0 | 0.002 |